Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 7/20 | 0.69 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | HRH2 | P25021 | 1/20 | 0.69 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.69 |
| ▸ | HTR2A | P28223 | 1/20 | 0.69 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.69 |
| ▸ | HTR2B | P41595 | 1/20 | 0.69 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.69 |
| ▸ | PDE4A | P27815 | 2/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7832281 | 0.85 | TLR7 (0.63) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL14958433 | 0.85 | TLR7 (0.60) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL13435161 | 0.83 | TLR7 (0.74) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL4830500 | 0.82 | TLR7 (0.72) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL4562038 | 0.82 | TLR7 (0.72) | TLR7PDE4DLMNAPOLBHRH2 | |
| Imiquimod SCHEMBL570774 | 0.82 | TLR7 (1.00) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL14667666 | 0.82 | TLR7 (0.72) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL1774913 | 0.82 | TLR7 (0.72) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL1774937 | 0.82 | TLR7 (0.72) | TLR7PDE4DLMNAPOLBHRH2 | |
| SCHEMBL29378640 | 0.82 | TLR7 (0.72) | TLR7PDE4DLMNAPOLBHRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9540407-B2 | Phospholipid drug analogs | UROGEN PHARMA LTD (IL) | 2017-01-10 | — | — | US | disclosed |
| US-20160090395-A1 | PHOSPHOLIPID DRUG ANALOGS | BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT (GB) | 2016-03-31 | — | — | US | disclosed |
| US-9180183-B2 | Phospholipid drug analogs | TELORMEDIX SA (CH) | 2015-11-10 | — | — | US | disclosed |
| US-9173935-B2 | Phospholipid drug analogs | TELORMEDIX SA (CH) | 2015-11-03 | — | — | US | disclosed |
| US-9173936-B2 | Phospholipid drug analogs | TELORMEDIX SA (CH) | 2015-11-03 | — | — | US | disclosed |
| US-9050319-B2 | Phospholipid drug analogs | TELORMEDIX, SA (CH) | 2015-06-09 | — | — | US | disclosed |
| US-20130273144-A1 | PHOSPHOLIPID DRUG ANALOGS | BIOPHARMA CREDIT PLC (GB) | 2013-10-17 | — | — | US | disclosed |
| US-20130267481-A1 | PHOSPHOLIPID DRUG ANALOGS | BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT (GB) | 2013-10-10 | — | — | US | disclosed |
| US-20130266635-A1 | PHOSPHOLIPID DRUG ANALOGS | BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT (GB) | 2013-10-10 | — | — | US | disclosed |
| US-20120009247-A1 | PHOSPHOLIPID DRUG ANALOGS | BIOPHARMA CREDIT PLC (GB) | 2012-01-12 | — | — | US | disclosed |
| US-20120003298-A1 | METHODS FOR INDUCING AN IMMUNE RESPONSE | TELORMEDIX SA (CH) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120003298-A1 | METHODS FOR INDUCING AN IMMUNE RESPONSE | CD4, IL4, CCR4 | TLR7 20/4885PDE4D 2947/4885LMNA 3863/4885 |
| US-20130267481-A1 | PHOSPHOLIPID DRUG ANALOGS | PHOSPHO1, PXMP4, SGMS1 | TLR7 1935/4885PDE4D 184/4885LMNA 786/4885 |
| US-20130273144-A1 | PHOSPHOLIPID DRUG ANALOGS | PHOSPHO1, PXMP4, SGMS1 | TLR7 1935/4885PDE4D 184/4885LMNA 786/4885 |
| US-20160090395-A1 | PHOSPHOLIPID DRUG ANALOGS | PHOSPHO1, PXMP4, SGMS1 | TLR7 1935/4885PDE4D 184/4885LMNA 786/4885 |
| US-20130266635-A1 | PHOSPHOLIPID DRUG ANALOGS | PHOSPHO1, PXMP4, SGMS1 | TLR7 1935/4885PDE4D 184/4885LMNA 786/4885 |
| US-20120009247-A1 | PHOSPHOLIPID DRUG ANALOGS | PHOSPHO1, PXMP4, SGMS1 | TLR7 1935/4885PDE4D 184/4885LMNA 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.